RET (REarranged during Transfection) gene fusions are oncogenic drivers identified across various solid tumor types. These fusions result in a chimeric oncoprotein combining the RET…
RET fusion-positive thyroid cancer represents a distinct molecular subset of differentiated thyroid cancers, predominantly papillary thyroid carcinoma (PTC) and poorly differentiated thyroid carcinoma (PDTC). RET…